GTG
MEDIA, JOBS & RESOURCES for the COMMON GOOD

Australasian Leukaemia & Lymphoma Group

Contact

Name: Dilu Uduwela

Position: Events and Website Manager

Email: info@allg.org.au

Website: http://www.allg.org.au

Address

Ground Floor 35 Elizabeth St

Richmond VIC 3121

Share us on social media

Follow

Our Mission / Objective

To improve the treatment and lives of patients with leukaemia, lymphoma and other haematological malignancies by advancing leading edge clinical trials in Australasia, and to be regarded by the local and international communities as the peak research body for these diseases within the ALLG’s geographical areas of operation and influence.

Our Services

The ALLG provides the infrastructure and governance necessary for Australian and New Zealand clinicians and scientists to work together to conduct multi-disciplinary clinical research into blood cancers. Currently, more than 600 clinicians, scientists and support staff across Australia and New Zealand contribute to ALLG research.

By conducting multi-site, collaborative clinical trials, ALLG researchers play a pivotal role in influencing blood cancer treatment practice worldwide and improving outcomes for people suffering from these diseases.

Our Beneficiaries

The activities of the ALLG benefit those suffering from blood malignancies in Australia, New Zealand and internationally. All activities are focused on improving the treatment they receive from clinical trial research.

Projects in Progress

Clinical Trials

Please click here to see a list of our current clinical trials.

National Blood Cancer Registry (NBCR)

The NBCR was designed to give real world data linking demographic, cancer cytogenetic, clinical and treatment outcome information and offers a longitudinal clinical pathway for each participating patient.

The NBCR fills current gaps in knowledge and research capacity to form a collaborative model framework. The framework is equipped to develop evidenced-based policy and improve the diagnosis, treatment and outcomes for patients with Acute Myeloid Leukaemia (AML), Acute Lymphoblastic Leukaemia (ALL) and Uncommon Lymphomas.

By systematically collecting patient information, the NBCR provides serial longitudinal data for blood cancer patients throughout Australia and New Zealand.

Biobank

A biobank is a central repository of human tissue samples from blood, bone marrow or other tissue. The biobank receives and stores specimens from patients with haematological malignancies participating in ALLG investigator initiated clinical trials and the ALLG National Blood Cancer Registry (NBCR).

The aim of the biobank is to facilitate the conduct of research thereby augmenting the benefits of our clinical research into haematological malignancies. The function of the biobank will be to provide samples from patients with these diseases for use in ethically approved research projects thereby facilitating a wide range of research activities. The ultimate goal of facilitating such research is to improve our understanding of the processes leading to the development of haematological malignancies, factors which govern the variable response to current treatments and ultimately the development of more effective therapies for patients suffering from haematological malignancies.

Our People

CEO

Delaine Smith, CEO

Leadership Team

Kelly Hetherton, Business Manager

Bebe Beckerman, Philanthropy & Fundraising Manager

Bernadette Marr, Marketing & Communications Manager

Dilu Uduwela, Events & Website Manager

Brock Patton, Protocol Development Coordinator 

Suzanne Cake, Senior Clinical Research Associate

Tracey Gerber, Senior Clinical Research Associate 

Amanda Jager, Senior Clinical Research Associate 

Names of Board Members

Peter T Kempen (Chairman)

A/Prof Peter Mollee

A/Prof Peter Bardy

Prue Deniz

Geraldine Gray

Malcolm McComas

Tina Rankovic 

Prof Andrew Roberts

Prof Philip Rowlings

Registration Information

ABN

96 066 593 100

Tax Deductible

Yes

How to help us

Wills and Bequests

A world without blood cancer could be the long-lasting legacy you leave behind to your loved ones.

When you leave a bequest to the ALLG, you are providing some of Australia’s leading researchers with the power to end blood cancer sooner.

We are always extremely grateful to those who leave their last gift to the advancement of blood cancer research. Whether the gift is cash, a whole or percentage of an estate, antique jewellery, paintings, real estate or shares, the ALLG is honoured to have you as someone leaving such a long-lasting impact.

General Donations

Research breakthroughs of the near future need perseverance and funding; we are so grateful to the generosity of donors in our community, whose contributions — both large and small — have enabled us to continue our work.

The gift you make today will make a difference in the life of someone who has blood cancer. Thank you for supporting breakthrough cancer research with your kind donation.

Other support

You can also support the ALLG by donating through your workplace, fundraising for the ALLG or purchasing an Entertainment Book with profits going directly to fund clinical trials. 

To find out more, visit our website

Work with us

Please visit our website for any new career opportunities. 

Volunteer with us

Our Annual Reports

Our Mission / Objective

To improve the treatment and lives of patients with leukaemia, lymphoma and other haematological malignancies by advancing leading edge clinical trials in Australasia, and to be regarded by the local and international communities as the peak research body for these diseases within the ALLG’s geographical areas of operation and influence.

Our Services

The ALLG provides the infrastructure and governance necessary for Australian and New Zealand clinicians and scientists to work together to conduct multi-disciplinary clinical research into blood cancers. Currently, more than 600 clinicians, scientists and support staff across Australia and New Zealand contribute to ALLG research.

By conducting multi-site, collaborative clinical trials, ALLG researchers play a pivotal role in influencing blood cancer treatment practice worldwide and improving outcomes for people suffering from these diseases.

Our Beneficiaries

The activities of the ALLG benefit those suffering from blood malignancies in Australia, New Zealand and internationally. All activities are focused on improving the treatment they receive from clinical trial research.

Projects in Progress

Clinical Trials

Please click here to see a list of our current clinical trials.

National Blood Cancer Registry (NBCR)

The NBCR was designed to give real world data linking demographic, cancer cytogenetic, clinical and treatment outcome information and offers a longitudinal clinical pathway for each participating patient.

The NBCR fills current gaps in knowledge and research capacity to form a collaborative model framework. The framework is equipped to develop evidenced-based policy and improve the diagnosis, treatment and outcomes for patients with Acute Myeloid Leukaemia (AML), Acute Lymphoblastic Leukaemia (ALL) and Uncommon Lymphomas.

By systematically collecting patient information, the NBCR provides serial longitudinal data for blood cancer patients throughout Australia and New Zealand.

Biobank

A biobank is a central repository of human tissue samples from blood, bone marrow or other tissue. The biobank receives and stores specimens from patients with haematological malignancies participating in ALLG investigator initiated clinical trials and the ALLG National Blood Cancer Registry (NBCR).

The aim of the biobank is to facilitate the conduct of research thereby augmenting the benefits of our clinical research into haematological malignancies. The function of the biobank will be to provide samples from patients with these diseases for use in ethically approved research projects thereby facilitating a wide range of research activities. The ultimate goal of facilitating such research is to improve our understanding of the processes leading to the development of haematological malignancies, factors which govern the variable response to current treatments and ultimately the development of more effective therapies for patients suffering from haematological malignancies.

Our People

CEO

Delaine Smith, CEO

Leadership Team

Kelly Hetherton, Business Manager

Bebe Beckerman, Philanthropy & Fundraising Manager

Bernadette Marr, Marketing & Communications Manager

Dilu Uduwela, Events & Website Manager

Brock Patton, Protocol Development Coordinator 

Suzanne Cake, Senior Clinical Research Associate

Tracey Gerber, Senior Clinical Research Associate 

Amanda Jager, Senior Clinical Research Associate 

Names of Board Members

Peter T Kempen (Chairman)

A/Prof Peter Mollee

A/Prof Peter Bardy

Prue Deniz

Geraldine Gray

Malcolm McComas

Tina Rankovic 

Prof Andrew Roberts

Prof Philip Rowlings

Registration Information

ABN

96 066 593 100

Tax Deductible

Yes

How to Help us

Wills and Bequests

A world without blood cancer could be the long-lasting legacy you leave behind to your loved ones.

When you leave a bequest to the ALLG, you are providing some of Australia’s leading researchers with the power to end blood cancer sooner.

We are always extremely grateful to those who leave their last gift to the advancement of blood cancer research. Whether the gift is cash, a whole or percentage of an estate, antique jewellery, paintings, real estate or shares, the ALLG is honoured to have you as someone leaving such a long-lasting impact.

General Donations

Research breakthroughs of the near future need perseverance and funding; we are so grateful to the generosity of donors in our community, whose contributions — both large and small — have enabled us to continue our work.

The gift you make today will make a difference in the life of someone who has blood cancer. Thank you for supporting breakthrough cancer research with your kind donation.

Other support

You can also support the ALLG by donating through your workplace, fundraising for the ALLG or purchasing an Entertainment Book with profits going directly to fund clinical trials. 

To find out more, visit our website

Work with us

Please visit our website for any new career opportunities. 

Volunteer with us

Our Annual Reports

PRINT

Featured Not for Profits


We aim to achieve better health for poor and vulnerable comm...

Burnet Institute



Autism SA

You Might Be Interested In

Dunlea Centre
pba inverse logo
Subscribe Twitter Facebook